Can GSK’s Hepatitis B Breakthrough Become a £2 Billion Opportunity?
GSK plc (NYSE:GSK) has reached two important regulatory milestones involving treatments for chronic hepatitis B and rectal cancer.
Billionaire Daniel Loeb Is Betting on These 2 Non-AI Stocks
Billionaire Daniel Loeb’s Third Point opened about 16 new positions during the second quarter. Two of the new buys sit well outside the AI trade, and we decided to focus on those for this article.
Hedge Funds
News & Analysis
Top Fund Managers
Best Performing Funds
Featured Content
Insider Trading
News & Analysis
Latest Insider Purchases
De bought 313,104 Liberty Latin America Ltd. shares at $20.95
De bought 17,596 Liberty Latin America Ltd. shares at $20.65
De bought 145,490 Liberty Latin America Ltd. shares at $21.00
Altman bought 800 Biocardia Inc. shares at $1.09
Engert bought 5,140 Enovis Corp shares at $19.46
Latest Insider Sales
Kandiah sold 498,728 Rackspace Technology Inc. shares at $3.21
Ainscow sold 23,678 Asp Isotopes Inc. shares at $3.89
Ainscow sold 25,000 Asp Isotopes Inc. shares at $3.91
Mann sold 83,759 Asp Isotopes Inc. shares at $4.10
Mann sold 83,758 Asp Isotopes Inc. shares at $3.92
Featured Content
Do not Miss
Lilly Launches Foundayo in the UK as NICE Review Continues
Eli Lilly and Company (NYSE:LLY) has launched Foundayo in the United Kingdom, making Britain the first European country where the company’s oral treatment for weight management and type 2 diabetes is...
Could New Long-Term Data Support Capricor’s Duchenne Therapy?
Capricor Therapeutics, Inc. (NASDAQ:CAPR) has gained another opportunity to make the case for deramiocel, its experimental cell therapy for Duchenne muscular dystrophy.
Could Roche and Lilly’s Blood Test Make Alzheimer’s Assessment More Accessible?
Testing for Alzheimer’s-related brain changes has traditionally depended on procedures that can be expensive, invasive, or difficult to access.
Regenxbio’s Gene Therapy Faces Another FDA Setback in Hunter Syndrome
Regenxbio Inc. (NASDAQ:RGNX) suffered another setback in its effort to bring RGX-121 to patients with Hunter syndrome.
Guardant Health Faces a $245 Million Patent Judgment, But Its Newer Tests Could Offer Protection
Guardant Health, Inc. (NASDAQ:GH) faces a costly legal setback after a US court ordered the cancer-testing company to pay more than $245.2 million in a DNA-sequencing patent dispute.
Alibaba’s Wan3.0 Expands Its AI Ambitions, Could Shareholders Be Paying the Bill?
Alibaba Group Holding Limited (NYSE:BABA) has introduced Wan3.0, its latest artificial-intelligence video-generation model, one day after announcing a HK$80 billion ($10.2 billion) share placement to ...
Five Below (FIVE) Reported Sales Growth and Authorized a $600M Repurchase Program. Can Recovery Fund Expansion and Capital Returns?
Five Below, Inc. (NASDAQ:FIVE) reported fiscal second-quarter net sales of $1.26 billion, up 22.9% from $1.03 billion one year earlier.
Guidewire (GWRE) Grew Fiscal 2026 ARR 19%. Can Cloud Economics Offset Slower Near-Term Growth?
Guidewire Software, Inc. (NYSE:GWRE) reported fiscal fourth-quarter revenue of $411.1 million, up 15%.
DocuSign (DOCU) Raised IAM’s Share of ARR to 15%. Can Platform Mix Lift Total ARR Growth Beyond Single Digits?
DocuSign, Inc. (NASDAQ:DOCU) reported fiscal second-quarter 2027 revenue of $875.7 million, up 9% year over year.
UiPath (PATH) Grew ARR 12% as Net Retention Rate Reached 109%. Can Agentic Automation Reaccelerate Expansion?
UiPath, Inc. (NYSE:PATH) reported fiscal second-quarter revenue of $410.3 million, up 13% year over year, while annualized renewal run-rate, or ARR, rose 12% to $1.938 billion. UiPath, Inc.
Victoria's Secret (VSXY) Delivered 9% Comparable-Sales Growth. Can Regular-Price Momentum Survive Higher Marketing Spend?
Victoria's Secret & Co. (NYSE:VSXY) reported fiscal second-quarter net sales of $1.611 billion, up 10%, while comparable sales increased 9%.
Aehr Test Systems (AEHR) Climbs 13%; Hedge Fund Holdings Rocket by Eightfold
Aehr Test Systems (NASDAQ:AEHR) saw its share price climb by 13.10 percent on Friday as investors began positioning their portfolios ahead of business updates next week.
Asana (ASAN) Reached a 10% Non-GAAP Operating Margin. Can Agentic Products Restore Expansion?
Asana, Inc. (NYSE:ASAN) reported fiscal second-quarter 2027 revenue of $216.4 million, up 10% year over year, and company-defined non-GAAP operating income of $21.8 million, equal to a 10.1% margin.
Toro Co (TTC) Grew Third-Quarter Sales 8.4%. Can Residential Gains Offset Professional Margin Compression?
The Toro Company (NYSE:TTC) reported fiscal third-quarter 2026 net sales of $1.226 billion, up 8.4% year over year.
Ambarella (AMBA) Grew 2Q Revenue 13.2% and Signed 7-Year Channel Agreements. Can Edge-AI Scale Reverse Margin Compression?
Ambarella, Inc. (NASDAQ:AMBA) reported fiscal second-quarter 2027 revenue of $108.1 million, up 13.2% from $95.5 million a year earlier.
Jim Cramer Bullish on MP Materials (MP) But Warns Investors Not to Expect Quick Results
A caller inquired about starting a position in MP Materials Corp. (NYSE:MP) during the lightning round of the September 2 episode of Mad Money, and Jim Cramer replied: I think it makes sense.
Concrete Pumping (BBCP) Raised Outlook and Initiated a Dividend After Revenue Growth. Can Infrastructure Demand Fund Returns and Deleveraging?
Concrete Pumping Holdings, Inc. (NASDAQ:BBCP) reported fiscal third-quarter revenue of $116.8 million, up 12.6%, as U.S. commercial, infrastructure, and data-center demand supported growth.
ChronoScale Says It Plans a 50 MW Microsoft AI Deployment. Can CHRN Fund the Build Without Diluting Shareholders?
ChronoScale said on August 27 that it plans with Microsoft to deploy 50 megawatts of AI infrastructure in North America using NVIDIA GB300 NVL72 systems and liquid cooling.
AWS Plans 2 Million More NVIDIA GPUs. Is This Better News for AMZN's Cloud Growth or NVDA's Backlog?
AWS and NVIDIA said on August 26 that Amazon's cloud plans to deploy two million additional Blackwell Ultra, Rubin, and Rubin Ultra GPUs during 2027 and 2028.
Entergy Says Google's Arkansas Solar Payments Could Total $2.1 Billion. Is Power Becoming Alphabet's New Bottleneck?
Newly reported records put dollar figures on power infrastructure for Google's West Memphis data center, but Entergy says the first $716 million headline understated the full economics.
Jim Cramer Discussed The Big Excitement At Gap Inc. (NYSE:GAP)
Apparel retailer Gap Inc. (NYSE:GAP) reported its second quarterearnings on August 27th.
Marvell Raised Its Outlook but Fell as Google Chip Revenue Stayed Distant. Has the AI Payoff Been Priced In? (Ready for review)
Marvell raised its annual forecasts on August 27, yet its shares fell as investors focused on the timing of revenue from a custom AI-chip relationship with Google.
Jim Cramer Thinks This Struggling Stock Could See A "Big Earnings Acceleration"
Human resources and financial software provider Workday, Inc. (NASDAQ:WDAY)'s shares are down by more than 10% over the past year and by more than 3% year-to-date.
Jim Cramer Revealed Why Ross Stores, Inc. (NASDAQ:ROST) Is "Kicking Butt"
Off price retailers The TJX Companies, Inc. (NYSE:TJX) and Ross Stores, Inc. (NASDAQ:ROST) have started to consistently appear on Jim Cramer's radar.
Jim Cramer Might Have Revealed A Major Hidden Nuclear Stock As Part Of His Discussion Of Materials & Chemical Companies
Materials firm Solstice Advanced Materials, Inc.
Coatue Opened Positions in Intel and Cerebras. Is the AI Chip Trade Broadening Beyond NVIDIA?
Coatue Management's Q2 filing disclosed a new position in Intel and, for the first time, a reportable position in newly public Cerebras.
Jim Cramer Flagged Another Risk For Adobe Inc. (NASDAQ:ADBE)
Alphabet Inc. (NASDAQ:GOOGL) and Adobe Inc. (NASDAQ:ADBE) are different firms whose businesses overlap.
Jim Cramer Says "Someone Must Know Something" About Broadcom Inc. (NASDAQ:AVGO)'s Post-Earnings Share Dip
Broadcom Inc. (NASDAQ:AVGO) dipped on September 3rd, the day after the firm reported its fiscal third quarter earnings report.
Jim Cramer Couldn't Stop Gushing About This Computer Hardware AI Stock
Computer hardware firm Dell Technologies Inc. (NYSE:DELL)'s shares closed 15.8% higher the day after the firm reported its second fiscal quarter earnings report.
CrowdStrike and Palo Alto Made the SaaSmageddon Survivor List. Can AI Expand Their Moats Faster Than It Compresses Software Prices?
An August 25 analysis of so-called SaaSmageddon survivors included CrowdStrike and Palo Alto Networks, arguing that security platforms may resist AI-driven software disruption better than ordinary applications...
There Are A Lot Of Zscaler Inc. (NASDAQ:ZS) Shorts, Says Jim Cramer
Cybersecurity firm Zscaler Inc. (NASDAQ:ZS)'s shares were lower in pre market trading the day the firm reported its fiscal fourth quarter earnings report.
Jim Cramer Said Meta Platforms, Inc. (NASDAQ: META)'s Big Court Win Was A Close Call
For more than a year, Jim Cramer has been quite favorable about Meta Platforms, Inc. (NASDAQ: META).
TiVo OS Added Generative AI Discovery. Can Xperi Take Share From Roku Without Owning the TV Screen?
Xperi used the IFA trade show on September 3 to unveil major TiVo OS updates, including a forthcoming Agent TiVo feature for natural-language discovery.
Jim Cramer Discussed A Little Known Chip Stock That He Likes
Qnity Electronics, Inc. (NYSE:Q) is a chemicals and materials firm that caters to the needs of the semiconductor and electronics industries.
Hedge Fund Resource Center Lists
11 Largest Uranium Producing Countries in the World
12 Fastest Declining Economies in the World in 2026
10 Most Popular Stocks on Robinhood in 2026
9 Undervalued Chemical Stocks to Buy According to Hedge Funds
7 Most Promising Psychedelic Stocks According to Hedge Funds
7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds
15 Innovative Healthcare Stocks to Buy According to Analysts
9 High Growth Small Cap Stocks That Are Profitable
20 Most Profitable Stocks of the Last 20 Years
15 High Growth Mid-Cap Stocks to Buy
Top 10 Oncology Stocks to Buy Now
10 Best Investments During A Recession
7 Best Rare Earth Stocks to Buy According to Hedge Funds
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending
New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST)
J.P. Morgan Lifts Natera, Inc. (NTRA) Target on Signatera Momentum
11 Best Cancer Stocks to Buy Right Now
Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut
20 Countries with the Highest Homeless Population
12 Countries with the Highest Bond Yields in the World
20 Countries with the Most Battle Tanks in the World
12 Best Nasdaq Stocks Under $20 to Buy Now
10 Best Low Beta Tech Stocks to Buy According to Analysts
10 Worst Performing Currencies of 2024
16 Countries with the Largest Proven Oil Reserves in the World
16 Highest Quality Chocolate Brands in the US
20 Countries with the Strongest Armies in the World
Top 13 English Speaking Countries in Asia
20 States with Highest Female to Male Ratio in the US
20 States with the Lowest Life Expectancy in the US
25 Cities with the Highest Homeless Population in the World
30 Cities with the Highest Weed Consumption in the US
25 Countries with the Highest Alcohol Consumption per Capita
10 Best Gold Stocks Under $30
10 Best Genomics Stocks To Buy Right Now
